XPhos Pd G1
CAS: 1028206-56-5
Ref. 3D-FX64703
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued | ||
| 250mg | Discontinued |
Product Information
Name:
XPhos Pd G1
Controlled Product
Synonyms:
- Palladium, [2-(2-aminoethyl)phenyl]chloro-, compd. with dicyclohexyl[2',4',6'-tris(1-methylethyl)[1,1'-biphenyl]-2-yl]phosphine (1:1)
- (2-Dicyclohexylphosphino-2',4',6'-triisopropyl-1,1'-biphenyl)[2-(2-aminoethyl)phenyl]palladium(ii) chloride
- Chloro(2-Dicyclohexylphosphino-2',4',6'-Triisopropyl-1,1'-Biphenyl)[2-(2-Aminoethyl)Phenyl]Palladium(Ii)
- Chloro(2-dicyclohexylphosphino-2',4',6'-tri-i-propyl-1,1'-biphenyl)[2-(2-aminoethyl)phenyl]palladium(II)methyl-t-butylether adduct
- XPhos Palladacycle
Description:
XPhos Pd G1 is a compound that has been synthesized for the treatment of neuroinflammatory, autoimmune, cardiovascular, and cancer disorders. This drug also acts as a nociceptive agent and has been shown to be effective in treating inflammatory pain. XPhos Pd G1 is an insoluble solid that can be prepared by cross-coupling reactions of imidazole derivatives with dioxane. It has been shown to have anti-infectious properties against bacteria and viruses including influenza A, respiratory syncytial virus (RSV), human immunodeficiency virus (HIV), and hepatitis B. XPhos Pd G1 also has metabolic effects on the body by reducing levels of pyridine compounds and increasing pyrazolyl concentrations in the blood stream.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
842.22 g/mol
Formula:
C41H59CINPPd
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
